Interestingly, flutamide, an antagonist of androgen receptor (AR), restored follicular growth [79], suggesting that AR may be a therapeutic target to treat the anovulatory effects of PCOS and showcasing the usefulness of ovarian organoids to understand ovarian dysfunction. Here, AR is linked to polycystic ovary syndrome.